BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 19431188)

  • 1. Modeling ATM mutant proteins from missense changes confirms retained kinase activity.
    Barone G; Groom A; Reiman A; Srinivasan V; Byrd PJ; Taylor AM
    Hum Mutat; 2009 Aug; 30(8):1222-30. PubMed ID: 19431188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.
    Verhagen MM; Last JI; Hogervorst FB; Smeets DF; Roeleveld N; Verheijen F; Catsman-Berrevoets CE; Wulffraat NM; Cobben JM; Hiel J; Brunt ER; Peeters EA; Gómez Garcia EB; van der Knaap MS; Lincke CR; Laan LA; Tijssen MA; van Rijn MA; Majoor-Krakauer D; Visser M; van 't Veer LJ; Kleijer WJ; van de Warrenburg BP; Warris A; de Groot IJ; de Groot R; Broeks A; Preijers F; Kremer BH; Weemaes CM; Taylor MA; van Deuren M; Willemsen MA
    Hum Mutat; 2012 Mar; 33(3):561-71. PubMed ID: 22213089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional consequences of sequence alterations in the ATM gene.
    Lavin MF; Scott S; Gueven N; Kozlov S; Peng C; Chen P
    DNA Repair (Amst); 2004; 3(8-9):1197-205. PubMed ID: 15279808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
    Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
    Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of heterochromatin on DSB repair.
    Goodarzi AA; Noon AT; Jeggo PA
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):569-76. PubMed ID: 19442252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ATM in DNA double strand break repair accounts for the radiosensitivity in human cells exposed to high linear energy transfer ionizing radiation.
    Xue L; Yu D; Furusawa Y; Okayasu R; Tong J; Cao J; Fan S
    Mutat Res; 2009 Nov; 670(1-2):15-23. PubMed ID: 19583974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATM-dependent DNA damage signaling pathway.
    Kitagawa R; Kastan MB
    Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive phosphorylation of ATM in lymphoblastoid cell lines from patients with ICF syndrome without downstream kinase activity.
    Goldstine JV; Nahas S; Gamo K; Gartler SM; Hansen RS; Roelfsema JH; Gatti RA; Marahrens Y
    DNA Repair (Amst); 2006 Apr; 5(4):432-43. PubMed ID: 16426903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
    Veuger SJ; Durkacz BW
    DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionizing radiation activates the ATM kinase throughout the cell cycle.
    Pandita TK; Lieberman HB; Lim DS; Dhar S; Zheng W; Taya Y; Kastan MB
    Oncogene; 2000 Mar; 19(11):1386-91. PubMed ID: 10723129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation.
    Wei F; Xie Y; Tao L; Tang D
    Cell Signal; 2010 Nov; 22(11):1783-9. PubMed ID: 20637859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
    Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
    Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients.
    Austen B; Barone G; Reiman A; Byrd PJ; Baker C; Starczynski J; Nobbs MC; Murphy RP; Enright H; Chaila E; Quinn J; Stankovic T; Pratt G; Taylor AM
    Br J Haematol; 2008 Sep; 142(6):925-33. PubMed ID: 18573109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
    Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of Sp1 in response to DNA damage by ataxia telangiectasia-mutated kinase.
    Olofsson BA; Kelly CM; Kim J; Hornsby SM; Azizkhan-Clifford J
    Mol Cancer Res; 2007 Dec; 5(12):1319-30. PubMed ID: 18171990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homologous recombination repair is regulated by domains at the N- and C-terminus of NBS1 and is dissociated with ATM functions.
    Sakamoto S; Iijima K; Mochizuki D; Nakamura K; Teshigawara K; Kobayashi J; Matsuura S; Tauchi H; Komatsu K
    Oncogene; 2007 Sep; 26(41):6002-9. PubMed ID: 17384674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling.
    Waddell N; Jonnalagadda J; Marsh A; Grist S; Jenkins M; Hobson K; Taylor M; Lindeman GJ; Tavtigian SV; Suthers G; Goldgar D; Oefner PJ; ; Taylor D; Grimmond S; Khanna KK; Chenevix-Trench G
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1169-81. PubMed ID: 17001622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome analysis of the Aspergillus nidulans AtmA (ATM, Ataxia-Telangiectasia mutated) null mutant.
    Malavazi I; Savoldi M; da Silva Ferreira ME; Soriani FM; Bonato PS; de Souza Goldman MH; Goldman GH
    Mol Microbiol; 2007 Oct; 66(1):74-99. PubMed ID: 17880424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single chemical modifications of the C-1027 enediyne core, a radiomimetic antitumor drug, affect both drug potency and the role of ataxia-telangiectasia mutated in cellular responses to DNA double-strand breaks.
    Kennedy DR; Gawron LS; Ju J; Liu W; Shen B; Beerman TA
    Cancer Res; 2007 Jan; 67(2):773-81. PubMed ID: 17234789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration.
    Yang DQ; Halaby MJ; Li Y; Hibma JC; Burn P
    Drug Discov Today; 2011 Apr; 16(7-8):332-8. PubMed ID: 21315178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.